…infarction Pharmacology & dosing Definition and pathophysiology Atherosclerosis and acute coronary syndromes have important inflammatory components. Inflammation contributes to atherothrombosis through activation of innate immune pathways…
…receptors at the cell surface, and thereby enhances removal of LDL C from the circulation. This mechanism differs from that of the monoclonal antibodies alirocumab…
…plasma. Two principal therapeutic strategies have emerged: Inhibition of circulating PCSK9 activity , using the monoclonal antibodies evolocumab and alirocumab. Inhibition of hepatic PCSK9 synthesis , using…
No matches.